Peanut allergies have been rising in children.
New research is offering hope to peanut allergy sufferers.
A large-scale trial suggests that oral immunotherapy treatment could allow sufferers to increase their tolerance to peanuts.
The idea is not that those with peanut allergies will be able to eat the nuts freely, but that their reactions could be reduced.
A pioneering new study is offering new hope to peanut allergy sufferers.
It may be possible to reduce the severity of allergic reactions to peanuts, research published in The Lancet Child & Adolescent Health suggests.
Peanut allergy is the leading cause of food-related anaphylaxis, the report states, with 6.1 million people suffering from the allergy in the US.
The number of sufferers has soared in recent decades, too,